We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Magnetically Controlled Tools Assist in Minimally Invasive Surgery

By HospiMedica International staff writers
Posted on 21 Jul 2009
A toolbox of magnetically controlled surgical instruments for minimally invasive surgery give surgeons greater maneuverability and range of motion, while reducing the number of entry ports into the abdominal cavity required for surgery.

The Magnetic Anchoring and Guidance System (MAGS) developed by researchers at the University of Texas (UT) Southwestern Medical Center (Dallas, TX, USA) and UT Arlington (USA), uses magnets outside the abdomen that attract others attached to instruments inserted within the abdomen, allowing internal movement. More...
The MAGS system could potentially benefit the emerging fields of laparoendoscopic single site surgery (LESS) and natural orifice translumenal endoscopic surgery (NOTES). UT Arlington and UT Southwestern Medical Center have reached an agreement with Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson (New Brunswick, NJ, USA), to further develop and manufacture the MAGS system.

"This is powerful technology and a very innovative concept,” said Daniel Scott, M.D., an associate professor of surgery and director of the Southwestern Center for Minimally Invasive Surgery. "These new instruments are much better than most of the currently available technology - offering much better stability and maneuverability.”

"A laparoscopic incision represents a fixed access point that has a limited working envelope that is conical in shape. We are working to develop the technology to move around more freely,” explained Jeffrey Cadeddu, M.D., a professor of urology and radiology and director of the clinical center for minimally invasive treatment of urologic cancer. "The magnetic maneuverability affords a much greater range of motion inside the abdominal cavity, allowing the surgical team to more easily position instruments in their optimum locations.”

"We are excited about the opportunity to codevelop the MAGS technology with the University of Texas at Arlington,” said Karen Licitra, company group chairman for Ethicon Endo-Surgery. "The collaboration between the clinical and engineering teams at UT Arlington is very much in line with our approach to achieving our vision of transforming patient care through innovation.”

Related Links:
University of Texas Southwestern Medical Center
University of Texas Arlington
Ethicon Endo-Surgery
Johnson & Johnson



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.